Cytena, a medtech spin-out of Freiburg University, has raised €1.1m ($1.25m) to support the development of its cell separation device. High-Tech Gründerfonds (HTGF) led a consortium of private investors in the seed round, which will be used to launch Cytena’s device, cy-clone, and duel its marketing activities. André Gross, technical director of Cytena, said: “Currently,…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.